Fulminant hepatic failure caused by Salmonella paratyphi A infection

Fahmi Yousef Khan1, Ahmed A Kamha, Ibrahim Y Alomary

  • 1Department of Medicine, Hamad General Hospital, PO Box 3050, Doha, Qatar. fakhanqal@yahoo.co.uk

Insights

Fulminant hepatic failure in a young adult was successfully treated following Salmonella paratyphi A infection. Prompt antibiotic therapy with ceftriaxone and dexamethasone led to patient recovery.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Critical Care Medicine

Background:

  • Salmonella paratyphi A infections can lead to severe complications.
  • Fulminant hepatic failure (FHF) is a rare but life-threatening condition.
  • Early diagnosis and intervention are crucial for managing FHF.

Observation:

  • A 29-year-old patient presented with fever, headache, vomiting, and altered mental status.
  • Clinical examination revealed deep jaundice and signs of acute illness.
  • Blood cultures confirmed Salmonella paratyphi A infection.

Findings:

  • The isolated Salmonella paratyphi A strain was sensitive to ceftriaxone and ciprofloxacin.
  • The patient received ceftriaxone and high-dose dexamethasone treatment.
  • Recovery was observed within two weeks of treatment initiation.

Implications:

  • This case highlights the potential for Salmonella paratyphi A to cause FHF.
  • Ceftriaxone combined with dexamethasone may be an effective treatment strategy.
  • Aggressive management in the intensive care unit (ICU) is vital for favorable outcomes.

Related Concept Videos

Reservoir of Infection01:30

Reservoir of Infection

Infectious diseases arise from intricate interactions between pathogens and their reservoirs. A reservoir of infection refers to the natural habitat where a pathogen lives, grows, and multiplies, serving as a continual source of infection. Reservoirs are broadly classified as either living or nonliving, and each plays a unique role in disease transmission, significantly influencing public health interventions and control strategies.Humans act as reservoirs for a wide array of pathogens,...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...